10/11/2013 7:59:01 AM
TherapeuticsMD raised $33 million in a secondary stock offering as new clinical data helped its stock reach a new high. The Boca Raton-based company (NYSE: TXMD) sold 13.75 million shares at $2.40 each. Stifel, Cowen and Co., and Lazard Capital Markets underwrote the offering. The money will support the development of its drug candidates.
Help employers find you! Check out all the jobs and post your resume.
comments powered by